Proceedings in oncology: Aren’t we back to the future?

Abstract

Three weeks ago Pamir Atagunduz, the Chief Editor of
Marmara Medical Journal, talked to me about his plans for
the Journal in the upcoming years with great excitement
and enthusiasm. I felt honored when he asked if I would
be interested in becoming the invited editor for the first of
the “Special Issue” series of Marmara Medical Journal. The
same day I started to plan how to accomplish an oncology
issue in a very short period of time. When I called Esra
Saglam, asking for a review due in 3 weeks, not only she
said yes, but also encouraged me with her great ideas. Here,
I would especially thank to all of the authors in this issue for
writing these manuscripts despite their very busy schedule.
Also, I owe special thanks to Bruce Minsky for his positive
approach in contributing to our Journal.
In addition to the current information regarding positive
interaction between immunotherapy and radiotherapy you
will find the latest developments on treatment of various
cancers in this “Special Issue - Oncology “.

Keywords

• -

References

1. References
2. Minsky B. Advances in the management of esophageal
3. cancer. Marmara Med J 2015; 28 (Special Issue 1):3-10.
4. doi:10.5472/mmj.10059
5. Dane F. What to expect from HER-2 directed therapies
6. in advanced gastric cancer? Marmara Med J 2015; 28
7. (Special Issue 1):11-15. doi:10.5472/mmj.87204
8. Akgun Z, Saglam EK. Neoadjuvant treatment in locally

9. advanced rectal cancer. Marmara Med J 2015; 28
10. (Special Issue 1):16-20. doi:10.5472/mmj.43321
11. Igdem S. Treatment of prostate cancer by hypofractionated
12. radiotherapy. Marmara Med J 2015; 28 (Special Issue
13. :21-23. doi:10.5472/mmj.11680
14. Bavbek S. How to approach castration-resistant prostate
15. cancer? Marmara Med J 2015; 28 (Special Issue 1):24-
16. doi:10.5472/mmj.80248
17. http://www.accessdata.fda.gov/drugsatfda_docs/
18. appletter/2015/207103Orig1s000ltr.pdf
19. Aktas B. CDK inhibitors in hormone receptor positive
20. advanced breast cancer. Marmara Med J 2015; 28
21. (Special Issue 1):35-39. doi:10.5472/mmj.77406
22. Anacak Y, Kamer S, Sert F. Combining radiotherapy with
23. immunotherapy. Marmara Med J 2015; 28 (Special Issue
24. :40-44. doi:10.5472/mmj.34632
25. ht tp: / /www.fda.gov/NewsEvents/Newsroom/
26. PressAnnouncements/ucm436534.htm
27. https://clinicaltrials.gov/ct2/show/NCT01642004?term
28. =CheckMate+017&rank=1
29. http://www.medscape.com/viewarticle/840890